Please login to the form below

Not currently logged in
Email:
Password:

insomnia

This page shows the latest insomnia news and features for those working in and with pharma, biotech and healthcare.

Artificial intelligence in healthcare

Artificial intelligence in healthcare

reborn as an insomnia therapy.

Latest news

More from news
Approximately 4 fully matching, plus 78 partially matching documents found.

Latest Intelligence

  • Innovation in merger control and the impact on the pharmaceutical sector Innovation in merger control and the impact on the pharmaceutical sector

    As a remedy, Pfizer divested its development programme. In Johnson &Johnson/Actelion, the merging parties were separately developing new treatments for insomnia, using the same novel mechanism of action. ... The Commission was concerned that post-merger,

  • Pharma deals in September 2015 Pharma deals in September 2015

    Let's deal with the pain first …. After last month's deal with Eisai for lemborexant, a phase III insomnia treatment, Purdue Pharma is refocusing on its pain portfolio by

More from intelligence
Approximately 0 fully matching, plus 2 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 2 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Kendle Healthcare

Company founder Neil Kendle was a pioneer in opinion leader engagement. In 2003, Neil brought together a small, dedicated team...

Latest intelligence

China’s clinical trial shake-up
As many of the obstacles to running clinical trials in China fall away, the country is proving to be a better research location...
Alzheimer’s disease – is Europe prepared if a breakthrough treatment becomes available?
Healthcare leaders in the European Union should begin preparing for a breakthrough now...
The UK’s new five-year pricing agreement
Pharma has agreed to capped growth again - in exchange for uptake promises...

Infographics